Sample result
Human insulin's gene
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
- Search
- DNA → Patent DNA · Automatic (BLAST)
- Set
- Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 3,194 sequences, 1,584 publications, 1,066 families
Each query returns up to 5,000 sequences and 5 alignments per sequence. BLAST may miss matches. These results do not establish patentability.
Patents
1,584 publications in 1,066 families match these filters.
-
US 11369670-B22022-06-28
Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host
Institut Pasteur and Centre National de la Recherche Scientifique
Query Match 22.1%Identity 87.7%
Best alignment
Query 228 to 333, hit 6668 to 6773. Positions start at 1 and include both ends.
Query 228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287 ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || ||||| Hit 6668 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6727 Query 288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 |||||||||||||| |||||||| ||||||||||||||||||||| Hit 6728 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 677393 of 106 identical, no gaps.
-
US 11649264-B22023-05-16
Methods and products for genetic engineering
Institut National De La Sante Et De La Recherche Medicale (INSERM), Centre National De La Recherche Scientifique (CNRS), Ecole Normale Superieure De Lyon and Universite De Claude Bernard Lyon 1
Query Match 22.1%Identity 87.7%
Best alignment
Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.
Query 228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287 ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || ||||| Hit 6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841 Query 288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 |||||||||||||| |||||||| ||||||||||||||||||||| Hit 6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 688793 of 106 identical, no gaps.
-
US 12049480-B22024-07-30
Methods and products for genetic engineering
Institut National de la Sante et de la Recherche Medicale (INSERM) et al
Query Match 22.1%Identity 87.7%Family of 3
Best alignment and family
Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.
Query 228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287 ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || ||||| Hit 6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841 Query 288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 |||||||||||||| |||||||| ||||||||||||||||||||| Hit 6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 688793 of 106 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 12049480-B22024-07-30
- US 12202860-B22025-01-21
- US 12365707-B22025-07-22
-
US 12173290-B22024-12-24
Materials and methods for controlling gene editing
CRISPR THERAPEUTICS AG and BAYER HEALTHCARE LLC
Query Match 22.1%Identity 87.7%
Best alignment
Query 228 to 333, hit 5375 to 5480. Positions start at 1 and include both ends.
Query 228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287 ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || ||||| Hit 5375 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 5434 Query 288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 |||||||||||||| |||||||| ||||||||||||||||||||| Hit 5435 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 548093 of 106 identical, no gaps.
-
JP 2025063185-A2025-04-15
METHODS AND PRODUCTS FOR GENETIC ENGINEERING
Applicants [Refer to the patent publication]
Query Match 22.1%Identity 87.7%
Best alignment
Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.
Query 228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287 ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || ||||| Hit 6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841 Query 288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 |||||||||||||| |||||||| ||||||||||||||||||||| Hit 6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 688793 of 106 identical, no gaps.
-
JP 2025500874-A2025-01-15
POLYCISTRONIC EXPRESSION OF GUT PEPTIDES
MeiraGTx UK II Limited
Query Match 21.9%Identity 100.0%
Best alignment
Query 1 to 73, hit 1 to 73. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCT 73 ||||||||||||| Hit 61 CCAGCCGCAGCCT 7373 of 73 identical, no gaps.
-
KR 1020010099687-A2001-11-09
DELIVERY SYSTEM FOR PORCINE SOMATOTROPIN
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 67 CCAGCCGCAGCC 7872 of 72 identical, no gaps.
-
US 6420345-A2002-07-16
Methods and reagents for inhibiting angiogenesis
Cell Genesys, Inc. and GPC Biotech Inc.
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2002527112-A2002-08-27
Delivery system of porcine somatotropin
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, UNIVERSITY OF WESTERN SYDNEY,PIG RESEARCH AND DEVELOPMENT CORP
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 67 CCAGCCGCAGCC 7872 of 72 identical, no gaps.
-
JP 2002538182-A2002-11-12
Method and reagent for inhibiting angiogenesis
CELL GENESYS INC,GPC BIOTECH INC
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 6521602-A2003-02-18
Anti-neoplastic compositions and uses thereof
GPC Biotech Inc. and Cell Genesys, Inc.
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 6967089-A2005-11-22
Delivery system for porcine somatotropin
Commonwealth Scientific and Industrial Research Organisation, University of Western Sydney (Nepean) and Pig Research and Development Corporation
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 67 CCAGCCGCAGCC 7872 of 72 identical, no gaps.
-
KR 1020130010121-A2013-01-25
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
INTREXON CORPORATION
Query Match 21.6%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020130010121-A2013-01-25
- EP 2550359-A12013-01-30
- KR 1020170125121-A2017-11-13
- KR 1020180108886-A2018-10-04
- US 10584351-B22020-03-10
-
JP 2013527753-A2013-07-04
Vectors Conditionally Expressing Therapeutic Proteins, Host Comprising the Vectors, and Uses Thereof
INTREXON CORPORATION
Query Match 21.6%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 61/316792.
- JP 2013527753-A2013-07-04
- JP 2017006118-A2017-01-12
- JP 2018011597-A2018-01-25
-
EP 3155003-A22017-04-19
AMYLOID BETA EXPRESSION CONSTRUCTS AND USES THEREFOR
THE WHITEHEAD INST FOR BIOMEDICAL RES
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 5 to 76. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 5 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 64 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 65 CCAGCCGCAGCC 7672 of 72 identical, no gaps.
-
JP 2017517269-A2017-06-29
AMYLOID BETA EXPRESSION CONSTRUCTS AND USES THEREFOR
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Query Match 21.6%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 72, hit 5 to 76. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 5 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 64 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 65 CCAGCCGCAGCC 7672 of 72 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017517269-A2017-06-29
- US 9822156-B22017-11-21
-
WO 2018033254-A22018-02-22
RNA FOR CANCER THERAPY
CUREVAC AG
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2018518946-A2018-07-19
Modified UBE3A Gene for a Gene Therapy Approach for Angelman Syndrome
University of South Florida
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
KR 1020190039969-A2019-04-16
RNA FOR CANCER THERAPY
CUREVAC AG
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2019526556-A2019-09-19
RNA for cancer therapy
CureVac AG
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
WO 2019193183-A22019-10-10
NOVEL YELLOW FEVER NUCLEIC ACID MOLECULES FOR VACCINATION
CUREVAC AG
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2020528739-A2020-10-01
Modified UBE3A Gene for a Gene Therapy Approach for Angelman Syndrome
University of South Florida
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2022525564-A2022-05-17
VECTOR AND METHOD FOR TREATING ANGELMAN SYNDROME
PTC Therapeutics,University of South Florida,Edwin Weeber,Min Jung Kim, Liangxian Cao,Antonio Arulanandam,Kevin Nash
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
KR 1020220116490-A2022-08-23
BCR TRANSGENIC MICE WITH A COMMON LEADER SEQUENCE
BRISTOL-MYERS SQUIBB COMPANY
Query Match 21.6%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220116490-A2022-08-23
- JP 2023508290-A2023-03-02
-
US 11524066-B22022-12-13
Henipavirus vaccine
CureVac SE
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 11534500-B22022-12-27
Modified UBE3A gene for a gene therapy approach for angelman syndrome
University of South Florida
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 11602557-B22023-03-14
Bunyavirales vaccine
Cure Vac SE
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 12201682-B22025-01-21
Henipavirus vaccine
CureVac SE
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
US 12397048-B22025-08-26
Bunyavirales vaccine
CureVac SE
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
KR 1020250161626-A2025-11-17
PPT1 GENE THERAPY
Spark Therapeutics, Inc
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
JP 2026511472-A2026-04-14
PPT1 Gene Therapy
Spark Therapeutics, Inc
Query Match 21.6%Identity 100.0%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 |||||||||||| Hit 61 CCAGCCGCAGCC 7272 of 72 identical, no gaps.
-
WO 0125278-A12001-04-12
C-peptide for the improved production of insulin and insulin analogues
Aventis Pharma Deutschland GmbH (DE)
Query Match 20.7%Identity 100.0%
Best alignment
Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.
Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252 |||||||||||||||||||||||||| ||||||||||||||||||||||| ||||||||| Hit 13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72 Query 253 TCCCTGCAGAAGCG 266 |||||||||||||| Hit 73 TCCCTGCAGAAGCG 8672 of 74 identical, no gaps.
-
KR 1020027004275-A2002-04-02
C-peptide for the improved production of insulin and insulin analogues
Query Match 20.7%Identity 100.0%
Best alignment
Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.
Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252 |||||||||||||||||||||||||| ||||||||||||||||||||||| ||||||||| Hit 13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72 Query 253 TCCCTGCAGAAGCG 266 |||||||||||||| Hit 73 TCCCTGCAGAAGCG 8672 of 74 identical, no gaps.
-
JP 2003511018-A2003-03-25
C peptide improving the production of insulin and insulin analog
AVENTIS PHARMA DEUTSCHLAND GMBH
Query Match 20.7%Identity 100.0%
Best alignment
Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.
Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252 |||||||||||||||||||||||||| ||||||||||||||||||||||| ||||||||| Hit 13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72 Query 253 TCCCTGCAGAAGCG 266 |||||||||||||| Hit 73 TCCCTGCAGAAGCG 8672 of 74 identical, no gaps.
-
WO 9941390-A21999-08-19
Expression vector for the production of dead proteins
HUELS CHRISTOPH (DE)
Query Match 19.4%Identity 95.8%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 || ||| |||| Hit 61 CCGGCCCAAGCC 7269 of 72 identical, no gaps.
-
JP 2002503474-A2002-02-05
Expression vector for producing DEAD protein
AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG
Query Match 19.4%Identity 95.8%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 || ||| |||| Hit 61 CCGGCCCAAGCC 7269 of 72 identical, no gaps.
-
US 6582691-A2003-06-24
Expression vector for the production of dead proteins
Aventis Research & Technologies GmbH & Co.
Query Match 19.4%Identity 95.8%
Best alignment
Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCC 72 || ||| |||| Hit 61 CCGGCCCAAGCC 7269 of 72 identical, no gaps.
-
EP 3655006-A12020-05-27
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
AKSTON BIOSCIENCES CORP
Query Match 19.4%Identity 88.8%Family of 14
Best alignment and family
Query 71 to 162, hit 56 to 147. Positions start at 1 and include both ends.
Query 71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130 |||| |||||||| |||||||||||||| ||||||||||||||||| || || ||||||| Hit 56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGTATCTCGTGTGCG 115 Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGACC 162 | || || |||||||||||||| |||||| || Hit 116 GCGAGCGGGGCTTCTTCTACACCCCCAAGGCC 14781 of 92 identical, no gaps.
Family of 14
Grouped by the same title and applicant. No priority claim is on record.
- EP 3655006-A12020-05-27
- US 10851147-B22020-12-01
- US 10870686-B22020-12-22
- KR 1020210029210-A2021-03-15
- US 10947292-B22021-03-16
- US 10961294-B22021-03-30
- WO 2021126584-A12021-06-24
- US 11261229-B22022-03-01
- US 11267862-B22022-03-08
- KR 1020220115975-A2022-08-19
- US 11673934-B22023-06-13
- US 11773151-B22023-10-03
- US 11919935-B22024-03-05
- US 12606605-B22026-04-21
-
US 11186623-B22021-11-30
Ultra-long acting insulin-Fc fusion proteins and methods of use
Akston Bioscience Corporation
Query Match 19.4%Identity 88.8%
Best alignment
Query 71 to 162, hit 56 to 147. Positions start at 1 and include both ends.
Query 71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130 |||| |||||||| |||||||||||||| ||||||||||||||||| || || ||||||| Hit 56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGTATCTCGTGTGCG 115 Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGACC 162 | || || |||||||||||||| |||||| || Hit 116 GCGAGCGGGGCTTCTTCTACACCCCCAAGGCC 14781 of 92 identical, no gaps.
-
KR 1020250098964-A2025-07-01
Long-acting insulin gene construct and uses thereof
POSTECH Research and Business Development Foundation
Query Match 19.1%Identity 90.0%
Best alignment
Query 73 to 168, hit 1 to 96. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 || || ||||| |||||||||||||| ||||||||||| || || ||||| |||||||| Hit 1 TTCGTCAACCAGCACCTGTGCGGCTCCCACCTGGTGGAGGCGCTGTACCTGGTGTGCGGA 60 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGG 168 || || |||||||||||||| |||||| |||||||| Hit 61 GAGCGCGGCTTCTTCTACACGCCCAAGGCCCGCCGG 9683 of 96 identical, no gaps.
-
EP 0367163-A21990-05-09
Process for producing an insulin precursor in streptomyces.
HOECHST AKTIENGESELLSCHAFT
Query Match 18.8%Identity 89.4%
Best alignment
Query 73 to 162, hit 16 to 105. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 || || ||||| |||||||||||||| ||||| ||||| || |||||||| ||||||||| Hit 16 TTCGTCAACCAGCACCTGTGCGGCTCGCACCTCGTGGAGGCCCTCTACCTGGTGTGCGGG 75 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162 || || |||||||||||||| ||||||||| Hit 76 GAGCGCGGCTTCTTCTACACCCCCAAGACC 10579 of 90 identical, no gaps.
-
EP 0376156-A21990-07-04
Insulin derivatives, process for their preparation, their use and pharmaceutical compositions containing them.
HOECHST AKTIENGESELLSCHAFT
Query Match 18.8%Identity 88.9%
Best alignment
Query 73 to 162, hit 180 to 91. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 || || ||||| |||||||||||||| ||||| ||||| || |||||||| ||||||||| Hit 180 TTCGTCAACCAGCACCTGTGCGGCTCGCACCTCGTGGAGGCCCTCTACCTGGTGTGCGGG 121 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162 || || |||||||||||||| ||||||||| Hit 120 GAGCGCGGCTTCTTCTACACCCCCAAGACC 9179 of 90 identical, no gaps.
-
JP 2021530210-A2021-11-11
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
AKSTON BIOSCIENCES CORPORATION
Query Match 18.3%Identity 88.3%Family of 2
Best alignment and family
Query 71 to 161, hit 56 to 146. Positions start at 1 and include both ends.
Query 71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130 |||| |||||||| |||||||||||||| ||||||||||||||||| | || ||||||| Hit 56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGGAACTCGTGTGCG 115 Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGAC 161 | || || |||||||||||||| || ||||| Hit 116 GCGAGCGGGGCTTCTTCTACACCCCTAAGAC 14679 of 91 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/692507.
- JP 2021530210-A2021-11-11
- JP 2024045117-A2024-04-02
-
WO 0210449-A22002-02-07
Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome
Compugen Inc. (US)
Query Match 18.0%Identity 100.0%
Best alignment
Query 69 to 128, hit 1 to 60. Positions start at 1 and include both ends.
Query 69 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 128 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 6060 of 60 identical, no gaps.
-
JP 2004508019-A2004-03-18
OLIGONUCLEOTIDE LIBRARY FOR DETECTING RNA TRANSCRIPTS AND SPLICE VARIANTS THAT POPULATE A TRANSCRIPTOME
Avi SHOSHAN,Alon WASSERMAN,Eli MINTZ,Liat MINTZ,Simchon FAIGLER
Query Match 18.0%Identity 100.0%
Best alignment
Query 69 to 128, hit 1 to 60. Positions start at 1 and include both ends.
Query 69 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 128 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 6060 of 60 identical, no gaps.
-
US 11667689-B22023-06-06
Insulin-Fc fusion proteins and methods of use to treat cancer
Akston Biosciences Corporation
Query Match 17.7%Identity 86.6%Family of 3
Best alignment and family
Query 71 to 159, hit 56 to 144. Positions start at 1 and include both ends.
Query 71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130 |||| |||||||| |||||||||||||| ||||||||||||||||| || ||||||| Hit 56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGGCTCTCGTGTGCG 115 Query 131 GGGAACGAGGCTTCTTCTACACACCCAAG 159 | || || |||||||||||||| |||||| Hit 116 GCGAGCGGGGCTTCTTCTACACCCCCAAG 14477 of 89 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 11667689-B22023-06-06
- KR 1020250129737-A2025-08-29
- JP 2026506309-A2026-02-24
-
US 9745359-B22017-08-29
Protein and protein conjugate for diabetes treatment, and applications thereof
Query Match 17.6%Identity 93.7%
Best alignment
Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| ||| Hit 1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169 ||||| || ||||||||||||||||||||| || |||| Hit 61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 9883 of 98 identical, 1 gap.
-
US 10472404-B22019-11-12
Protein and protein conjugate for diabetes treatment, and applications thereof
ADDA Biotech Inc.
Query Match 17.6%Identity 93.7%
Best alignment
Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| ||| Hit 1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169 ||||| || ||||||||||||||||||||| || |||| Hit 61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 9883 of 98 identical, 1 gap.
-
US 11208451-B22021-12-28
Protein and protein conjugate for diabetes treatment, and applications thereof
Query Match 17.6%Identity 93.7%
Best alignment
Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| ||| Hit 1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169 ||||| || ||||||||||||||||||||| || |||| Hit 61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 9883 of 98 identical, 1 gap.
-
JP 1982009796-A1982-01-19
ADAPTOR OLIGODEOXYNUCLEOTIDE MOLECULE
CANADIAN PATENTS & DEV LTD
Query Match 17.3%Identity 92.1%
Best alignment
Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.
Query 73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132 ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| ||| Hit 1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60 Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162 ||||| || ||||||||||||||||||||| Hit 61 GAACGTGGTTTCTTCTACACACCCAAGACC 9077 of 90 identical, no gaps.
